Welcome to Petr Cígler Research Group!
We study new types of nanoparticles for use in therapeutics, imaging and diagnostics of diseases. Our nanomaterials are based either on bioorganic or inorganic cores and includes viral-like particles, fluorescent nanodiamonds and plasmonic systems. We focus on biocompatibilization of nanoparticles, their targeting to cells and on non-invasive, remote control of nanoparticles’ action in cells by external stimuli.
New papers

Inhibitor-GCPII interaction: Selective and robust system for targeting cancer cells with structurally diverse nanoparticles
Mol. Pharmaceutics
2018, doi:10.1021
/acs.molpharmaceut.7b00889.

Nat. Comm.
2017, 8, 14701.